PMGC Holdings (ELAB) Price to Sales (2023 - 2026)
PMGC Holdings' (ELAB) quarterly Price to Sales came in at 0.45 in Q2 2026, up 15.67% quarter-over-quarter from 0.39 in Q1 2026.
Analysis
PMGC Holdings (ELAB) Price to Sales (2023 - 2026) Analysis & Trends
PMGC Holdings has disclosed Price to Sales across 4 years of filings, most recently posting 0.45 for Q2 2026.
- In Q2 2026, Price to Sales changed N/A year-over-year to 0.45; the TTM figure through Jun 2026 stood at 0.23 (changed 0.34% YoY), while the FY2025 annual figure was 0.12, up 136.27% from the prior year.
- Price to Sales came in at 0.45 for Q2 2026 at PMGC Holdings, up from 0.39 in the prior quarter.
- In the past five years, Price to Sales ranged from a high of 562.58 in Q4 2023 to a low of 0.18 in Q4 2024.
- Average Price to Sales over 4 years is 138.04, with a median of 1.32 recorded in 2025.
- Year-over-year, Price to Sales plunged 99.97% in 2024 and jumped 33.72% in 2025.
- Over 4 years, Price to Sales stood at 562.58 in 2023, then sank by 99.97% to 0.18 in 2024, then jumped by 33.72% to 0.24 in 2025, then jumped by 90.01% to 0.45 in 2026.
- Per Business Quant data, the three most recent Price to Sales figures were 0.45 in Q2 2026, 0.39 in Q1 2026, and 0.24 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 207.26 Bn | 193.27 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.66 Bn | 176.48 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.52 Bn | 123.67 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.77 Bn | 73.78 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn |
| 6 | Moderna | 53.55 Bn | 48.41 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.38 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 31.68 Bn | 30.40 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.12 Bn | 29.12 Bn | 1.16 Mn |
| 10 | PMGC Holdings | 2.29 Mn | -16.50 Mn | 385,691.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.45 |
| Mar 31, 2026 | 0.39 |
| Dec 31, 2025 | 0.24 |
| Sep 30, 2025 | 0.98 |
| Mar 31, 2025 | 1.65 |
| Dec 31, 2024 | 0.18 |
| Sep 30, 2024 | 60.12 |
| Jun 30, 2024 | 361.92 |
| Mar 31, 2024 | 391.93 |
| Dec 31, 2023 | 562.58 |